Lucid Diagnostics (LUCD) Competitors $1.24 +0.05 (+3.78%) As of 11:29 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUCD vs. AVNS, ZIMV, KIDS, CBLL, SMLR, TMCI, DCTH, DRTS, NPCE, and RXSTShould you be buying Lucid Diagnostics stock or one of its competitors? The main competitors of Lucid Diagnostics include Avanos Medical (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), CeriBell (CBLL), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Alpha Tau Medical (DRTS), NeuroPace (NPCE), and RxSight (RXST). These companies are all part of the "medical equipment" industry. Lucid Diagnostics vs. Its Competitors Avanos Medical ZimVie OrthoPediatrics CeriBell Semler Scientific Treace Medical Concepts Delcath Systems Alpha Tau Medical NeuroPace RxSight Lucid Diagnostics (NASDAQ:LUCD) and AVANOS MEDICAL (NYSE:AVNS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk. Which has more risk and volatility, LUCD or AVNS? Lucid Diagnostics has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, AVANOS MEDICAL has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Is LUCD or AVNS more profitable? AVANOS MEDICAL has a net margin of -66.89% compared to Lucid Diagnostics' net margin of -1,476.35%. AVANOS MEDICAL's return on equity of 6.16% beat Lucid Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Lucid Diagnostics-1,476.35% N/A -120.43% AVANOS MEDICAL -66.89%6.16%4.57% Do analysts rate LUCD or AVNS? Lucid Diagnostics presently has a consensus price target of $3.70, indicating a potential upside of 199.60%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, analysts clearly believe Lucid Diagnostics is more favorable than AVANOS MEDICAL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lucid Diagnostics 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.67AVANOS MEDICAL 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Which has preferable valuation and earnings, LUCD or AVNS? Lucid Diagnostics has higher earnings, but lower revenue than AVANOS MEDICAL. AVANOS MEDICAL is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLucid Diagnostics$4.36M37.81-$45.53M-$1.19-1.04AVANOS MEDICAL$687.80M0.75-$392.10M-$10.07-1.11 Do institutionals & insiders believe in LUCD or AVNS? 74.0% of Lucid Diagnostics shares are held by institutional investors. Comparatively, 95.2% of AVANOS MEDICAL shares are held by institutional investors. 6.8% of Lucid Diagnostics shares are held by company insiders. Comparatively, 2.6% of AVANOS MEDICAL shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media refer more to LUCD or AVNS? In the previous week, Lucid Diagnostics had 3 more articles in the media than AVANOS MEDICAL. MarketBeat recorded 5 mentions for Lucid Diagnostics and 2 mentions for AVANOS MEDICAL. Lucid Diagnostics' average media sentiment score of 0.70 beat AVANOS MEDICAL's score of 0.30 indicating that Lucid Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lucid Diagnostics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AVANOS MEDICAL 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryLucid Diagnostics beats AVANOS MEDICAL on 11 of the 16 factors compared between the two stocks. Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LUCD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUCD vs. The Competition Export to ExcelMetricLucid DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$164.84M$6.92B$6.06B$10.57BDividend YieldN/A1.18%5.73%4.80%P/E Ratio-1.0426.3685.0727.47Price / Sales37.8128.02518.67200.70Price / CashN/A21.5837.5761.53Price / Book-1.585.2112.336.87Net Income-$45.53M$178.09M$3.32B$276.69M7 Day Performance1.23%-1.91%0.70%0.70%1 Month Performance16.51%6.15%10.27%8.83%1 Year Performance56.33%6.59%74.67%36.06% Lucid Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUCDLucid Diagnostics3.0987 of 5 stars$1.24+3.8%$3.70+199.6%+52.7%$164.84M$4.36M-1.0470News CoverageAnalyst UpgradeAVNSAvanos Medical1.5017 of 5 stars$11.57-1.9%N/A-51.5%$547.08M$692.50M-1.152,227Positive NewsAnalyst ForecastZIMVZimVie1.1699 of 5 stars$18.92-0.1%$17.75-6.2%+20.1%$534.31M$449.75M-27.031,770KIDSOrthoPediatrics4.6244 of 5 stars$18.24-2.8%$34.14+87.2%-31.9%$470.64M$220.73M-10.19200Positive NewsCBLLCeriBell2.0793 of 5 stars$12.57-0.6%$32.14+155.7%N/A$463.43M$65.44M-4.20N/APositive NewsSMLRSemler Scientific3.2113 of 5 stars$30.75+0.6%$74.25+141.5%-6.5%$452.43M$56.29M12.65120Gap UpTMCITreace Medical Concepts2.3021 of 5 stars$6.30-0.9%$9.83+56.1%+19.2%$401.78M$209.36M-7.97250Analyst ForecastDCTHDelcath Systems2.6002 of 5 stars$10.80-2.7%$24.50+126.9%+30.2%$388.29M$37.21M216.0060Analyst DowngradeGap UpDRTSAlpha Tau Medical2.2338 of 5 stars$4.22-2.1%$9.00+113.3%+82.9%$365.57MN/A-8.7980Gap DownNPCENeuroPace3.5751 of 5 stars$10.77-1.4%$16.60+54.1%+67.5%$361.25M$79.91M-12.82170Positive NewsRXSTRxSight2.8275 of 5 stars$8.49-3.5%$10.00+17.8%-84.6%$360.06M$139.93M-10.61220 Related Companies and Tools Related Companies AVNS Alternatives ZIMV Alternatives KIDS Alternatives CBLL Alternatives SMLR Alternatives TMCI Alternatives DCTH Alternatives DRTS Alternatives NPCE Alternatives RXST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUCD) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucid Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
